Загрузка...
Third generation EGFR TKIs: current data and future directions
Acquired T790 M mutation is the commonest cause of resistance for advanced non-small cell lung cancer (NSCLC) epidermal growth factor receptor (EGFR) mutant patients who had progressed after first line EGFR TKI (tyrosine kinase inhibitor). Several third generation EGFR TKIs which are EGFR mutant sel...
Сохранить в:
| Опубликовано в: : | Mol Cancer |
|---|---|
| Главные авторы: | , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
BioMed Central
2018
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5817792/ https://ncbi.nlm.nih.gov/pubmed/29455654 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12943-018-0778-0 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|